Nuclear Medicine SPECT-CT

Nuclear Medicine SPECT-CT, (sometime referred to as scintigraphy), uses radioactive tracers that are injected into a vein to assess the function of organs and musculoskeletal disorders at a molecular level. Radiation doses are comparable to x-ray examinations. Reactions to the tracers are extremely rare and the tests are therefore exceptionally safe and well tolerated.

Bone scanning is a well-established technique and is one of the most reliable, sensitive and valuable
procedures in scintigraphy. The scan can detect abnormalities weeks or months before routine skeletal x-rays. Single-photon emission computed tomography (SPECT) is an imaging modality that combines conventional scintigraphic and computed tomographic (CT) methods and has revolutionised imaging of the skeletal system. We are able to provide reporting of bone scans and SPECT/CT studies. These studies are available to referrers online using InteleViewer and InteleConnect.

Nuclear Medicine studies include whole body bones scans, hepatobiliary/gall bladder, infection/tumour, thyroid, renal, parathyroid, gastric emptying, colonic transit scans and sentinel node mapping.

The modalities are particularly useful in situations where MRI is contraindicated e.g. pacemakers or MRI/CT image quality is compromised with metal implants.

It is the only method able to localise areas of increased bone turnover in response to mechanical stress or endocrine, neoplastic and inflammatory conditions.

See more details here, or contact SRG.

This page was last updated at 1:03PM on November 3, 2020.